FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE — Original Application (Vitruvias Therapeutics, Inc.)

View source ↗

Summary

FDA approved an extended-release pramipexole dihydrochloride tablet under an Original Application for Vitruvias Therapeutics, indicated for Parkinson's disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Pramipexole dihydrochloride extended-release (pramipexole dihydrochloride)

Snippet

ORIG AP for PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE (PRAMIPEXOLE DIHYDROCHLORIDE)